Cannara Biotech Inc. (LOVE.V)
CAD 0.68
(0.0%)
CAD 0.68
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 57.26 Million | 35.84 Million | 17.02 Million | 2.55 Million | 2.09 Million | 432.63 Thousand |
| Cost of Revenue | 30.02 Million | 18.51 Million | 6.72 Million | 1.32 Million | 403.89 Thousand | 273.58 Thousand |
| Gross Profit | 27.23 Million | 17.33 Million | 10.29 Million | 1.22 Million | 1.69 Million | 159.05 Thousand |
| Operating Expenses | 15.34 Million | 12.35 Million | 9.99 Million | 13.15 Million | 11.91 Million | 1.97 Million |
| Selling, General and Administrative Expenses | 13.52 Million | 10.02 Million | 7.3 Million | 8.96 Million | 11.34 Million | 1.86 Million |
| Research and Development Expenses | 1.03 Million | 1.25 Million | 1.9 Million | 2.6 Million | - | - |
| Other Expenses | 792.03 Thousand | 1.07 Million | 785.71 Thousand | 1.58 Million | 566.32 Thousand | 109.67 Thousand |
| Cost and Expenses | 45.37 Million | 30.86 Million | 16.72 Million | 14.48 Million | 12.32 Million | 2.24 Million |
| Operating Income | 11.88 Million | 3.67 Million | 192.59 Thousand | -11.92 Million | -10.22 Million | -1.81 Million |
| Interest Expense | 5.29 Million | 1.91 Million | 1.56 Million | 1.32 Million | 1.51 Million | 319.93 Thousand |
| Income Tax Expense | - | -551.4 Thousand | 1.56 Million | 713.89 Thousand | 855.93 Thousand | 295.76 Thousand |
| Earnings before Tax | 6.94 Million | 2.3 Million | -1.52 Million | -13.09 Million | -12.97 Million | -2.11 Million |
| Net Income | 6.94 Million | 2.3 Million | -3.09 Million | -13.8 Million | -13.82 Million | -2.4 Million |
| Earnings Per Share Basic | 0.08 | 0.03 | -0.04 | -0.19 | -0.20 | -0.03 |
| Earnings Per Share Diluted | 0.08 | 0.03 | -0.04 | -0.19 | -0.20 | -0.03 |
| Weighted Average Shares Outstanding | 89.3 Million | 87.66 Million | 76.51 Million | 71.33 Million | 70.67 Million | 69.38 Million |
| Weighted Average Shares Outstanding (Diluted) | 89.3 Million | 87.84 Million | 76.51 Million | 71.33 Million | 70.67 Million | 69.38 Million |
| Gross Margin | 0.48 | 0.48 | 0.60 | 0.48 | 0.81 | 0.37 |
| EBIT Margin | 0.30 | 0.21 | 0.19 | -3.57 | -4.29 | -3.89 |
| Profit Margin | 0.12 | 0.06 | -0.18 | -5.41 | -6.59 | -5.57 |
| EBITDA | 17.18 Million | 9.54 Million | 3.22 Million | -9.14 Million | -10.87 Million | -1.68 Million |
| Earnings Before Tax Margin | 0.21 | 0.10 | 0.01 | -4.68 | -4.88 | -4.20 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 19.54 Million | 19.68 Million | 19.48 Million | 57.26 Million | 18.33 Million | 15.84 Million |
| Cost of Revenue | 19.17 Million | 15.54 Million | 11.24 Million | 30.02 Million | 8.43 Million | 7.34 Million |
| Gross Profit | 370.6 Thousand | 4.14 Million | 8.23 Million | 27.23 Million | 9.89 Million | 8.49 Million |
| Operating Expenses | 5.2 Million | 6.1 Million | 4.79 Million | 15.2 Million | 3.99 Million | 4.21 Million |
| Selling, General and Administrative Expenses | 4.85 Million | 6.1 Million | 4.17 Million | - | 3.5 Million | 3.78 Million |
| Research and Development Expenses | 349.82 Thousand | 319.94 Thousand | 210.19 Thousand | - | 306.3 Thousand | 262.44 Thousand |
| Other Expenses | -1.79 Million | - | - | - | - | - |
| Cost and Expenses | 24.37 Million | 21.64 Million | 16.03 Million | 45.23 Million | 12.42 Million | 11.55 Million |
| Operating Income | -4.83 Million | -1.95 Million | 3.43 Million | 11.88 Million | 5.83 Million | 4.28 Million |
| Interest Expense | 1.41 Million | 1.07 Million | 1.05 Million | 3.88 Million | 329.84 Thousand | 1.16 Million |
| Income Tax Expense | 3.00 | 3.44 Million | 1.05 Million | 3.88 Million | 329.75 Thousand | 1.16 Million |
| Earnings before Tax | 2.02 Million | -3.44 Million | 2.1 Million | 6.94 Million | 4.63 Million | 2.92 Million |
| Net Income | 2.02 Million | -3.44 Million | 2.1 Million | 6.94 Million | 4.63 Million | 2.92 Million |
| Earnings Per Share Basic | 0.02 | -0.04 | 0.02 | - | 0.05 | 0.03 |
| Earnings Per Share Diluted | 0.02 | -0.04 | 0.02 | - | 0.05 | 0.03 |
| Weighted Average Shares Outstanding | 90.01 Million | 90.01 Million | 90.22 Million | 89.3 Million | 90.3 Million | 87.66 Million |
| Weighted Average Shares Outstanding (Diluted) | 91.52 Million | 90.01 Million | 91.01 Million | 89.3 Million | 90.3 Million | 87.66 Million |
| Gross Margin | 0.02 | 0.21 | 0.42 | 0.48 | 0.54 | 0.54 |
| EBIT Margin | -0.17 | -0.03 | 0.25 | - | 0.34 | 0.34 |
| Profit Margin | 0.10 | -0.18 | 0.11 | 0.12 | 0.25 | 0.18 |
| EBITDA | -3.32 Million | -632.39 Thousand | 4.78 Million | - | 6.3 Million | 5.38 Million |
| Earnings Before Tax Margin | -0.25 | -0.10 | 0.18 | 0.21 | 0.32 | 0.27 |
TGNA
TYFG
603993
ALFEN
CPOP
BAMI